These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10861865)

  • 1. Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors.
    Wesierska-Gadek J; Bohrn E; Herceg Z; Wang ZQ; Wurzer G
    J Cell Biochem; 2000 Jun; 78(4):681-96. PubMed ID: 10861865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
    An WG; Hwang SG; Trepel JB; Blagosklonny MV
    Leukemia; 2000 Jul; 14(7):1276-83. PubMed ID: 10914553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
    Wagenknecht B; Hermisson M; Eitel K; Weller M
    Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of proteasome to its inhibitors increases during cAMP-induced differentiation of neuroblastoma cells in culture and causes decreased viability.
    Kumar B; Hanson AJ; Prasad KN
    Cancer Lett; 2004 Feb; 204(1):53-9. PubMed ID: 14744534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
    Milligan SA; Nopajaroonsri C
    Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts.
    Wesierska-Gadek J; Wang ZQ; Schmid G
    Cancer Res; 1999 Jan; 59(1):28-34. PubMed ID: 9892179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
    Chen F; Chang D; Goh M; Klibanov SA; Ljungman M
    Cell Growth Differ; 2000 May; 11(5):239-46. PubMed ID: 10845424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase.
    Agarwal ML; Agarwal A; Taylor WR; Wang ZQ; Wagner EF; Stark GR
    Oncogene; 1997 Aug; 15(9):1035-41. PubMed ID: 9285557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
    Blagosklonny MV; Wu GS; Omura S; el-Deiry WS
    Biochem Biophys Res Commun; 1996 Oct; 227(2):564-9. PubMed ID: 8878553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.
    Choi YH
    Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
    An WG; Chuman Y; Fojo T; Blagosklonny MV
    Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
    BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
    Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
    Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensatory expression of p73 in PARP-deficient mouse fibroblasts as response to a reduced level of regularly spliced wild-type p53 protein.
    Schmid G; Wang ZQ; Wesierska-Gadek J
    Biochem Biophys Res Commun; 1999 Feb; 255(2):399-405. PubMed ID: 10049720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress.
    Ullrich O; Ciftci O; Hass R
    Free Radic Biol Med; 2000 Nov; 29(10):995-1004. PubMed ID: 11084288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones.
    Ullrich O; Reinheckel T; Sitte N; Hass R; Grune T; Davies KJ
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6223-8. PubMed ID: 10339569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts.
    An B; Goldfarb RH; Siman R; Dou QP
    Cell Death Differ; 1998 Dec; 5(12):1062-75. PubMed ID: 9894613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress.
    Reinheckel T; Ullrich O; Sitte N; Grune T
    Arch Biochem Biophys; 2000 May; 377(1):65-8. PubMed ID: 10775442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.